Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antisense therapy

R Narayanan¹, S Akhtar

¹Roche Research Center, Hoffmann-La Roche, Inc., Nutley, NJ 07110, USA.

Current Opinion in Oncology

|November 1, 1996

Summary

This summary is machine-generated.

Antisense technology offers promising molecular therapeutics by inhibiting gene expression. Further research into its complex, sometimes sequence-independent, mechanisms is crucial for realizing its full therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prospective evaluation of the CASST score to guide elective tracheostomy following oral cancer surgery: challenges and clinical misalignment.

International journal of oral and maxillofacial surgery·2026

Same author

Development and Validation of Obesity Interpreter: A Mobile Application-Based Tool for Children and Adolescents.

Indian pediatrics·2026

Same author

Distinguishing Between SIAD and Cerebral Salt Wasting: Is Dynamic Copeptin Response the Answer?

Indian journal of pediatrics·2026

Same author

Clinical Course and Predictors of Metabolic Dysfunction Associated Steatotic Liver Disease in Obese Children and Adolescents.

Indian pediatrics·2026

Same author

Answer to the letter to the editor of T. Tanaka, et al. concerning "patients on antidepressants are more likely to be discharged to inpatient rehabilitation after lumbar fusion" by J. Dalton, et al. (Eur spine J 2025: doi: 10.1007/s00586-025-08815-y).

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2025

Same author

Virulent Beauveria bassiana OR500626 strain effectively control Tetranychus urticae.

Brazilian journal of biology = Revista brasleira de biologia·2025

Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026

Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026

Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026

Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026

Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026

Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026

See all related articles

Area of Science:

Molecular biology
Pharmacology
Drug discovery

Background:

Antisense technology utilizes sequence-specific inhibition of gene expression.
Oligodeoxynucleotides are being investigated as therapeutics for diseases like AIDS, cancer, and inflammation.
Current understanding suggests complex and potentially sequence-independent mechanisms of action for these drugs.

Purpose of the Study:

To highlight the therapeutic potential of antisense technology.
To emphasize the need for understanding the complex mechanisms of action of antisense oligodeoxynucleotides.
To underscore the importance of target validation in antisense-based drug development.

Main Methods:

Gene expression inhibition studies in cell culture models.

Related Experiment Videos

Development and clinical trial investigation of modified oligodeoxynucleotides.

Analysis of sequence-dependent and independent effects of antisense drugs.

Main Results:

Antisense techniques show promise for novel molecular therapeutics.
Cell culture models provide rationale for disease target identification.
Modified oligodeoxynucleotides are progressing through clinical trials for various diseases.

Conclusions:

Antisense oligodeoxynucleotides hold considerable promise as novel molecular drugs.
Elucidating the complex mechanisms of action is key to harnessing their therapeutic potential.
Further research is needed to develop effective and meaningful therapeutic modalities.